NCT04276493 2024-12-06Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without TislelizumabBeiGenePhase 1/2 Completed71 enrolled
NCT02658214 2020-08-20Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsAstraZenecaPhase 1 Completed32 enrolled
NCT01183663 2016-06-03Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)M.D. Anderson Cancer CenterPhase 1 Completed180 enrolled
NCT01233505 2014-04-02Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1 Terminated16 enrolled